Expertise

VerIQ’s strength lies in its people and partnerships. Our leadership team combines senior clinical and scientific figures from the UK’s leading orthopaedic and MedTech research centres.

• Prof. Andy Metcalfe FRCS, PhD – Chief Medical Officer
• Prof Edward Davis (Royal Orthopaedic Hospital, Birmingham)
• Prof Charles Craddock (University of Warwick and co-founder of ACT)
• Dr. Joe Dupere PhD, MBA – Chief Executive Officer

VerIQ is supported by a distinguished Clinical Advisory Board led by Chairman Mr Nick Smith (University Hospital Coventry and Warwickshire) and an extensive team of key opinion leaders who cover a wide range of disciplines and specialities.

VerIQ leverages the proven clinical trial excellence of the Warwick Clinical Trials Unit (CTU) — the UK’s top NIHR-funded CTU — with a record of delivering internationally recognised, high-impact studies published in NEJM, Lancet, and BMJ.

Our network integrates over 60 leading orthopaedic and MedTech centres across the UK, enabling unparalleled access to patients, clinicians, and research infrastructure. Together, this expertise powers VerIQ’s vision: to make the UK the preferred global destination for MedTech clinical research.